1. Home
  2. Live Updates
  3. Rug approvals

Live Breaking News & Updates on Rug approvals

Stay informed with the latest breaking news from Rug approvals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rug approvals and stay connected to the pulse of your community

Ozempic, weight-loss drugs rise and the fitness industry reacts

The increasing popularity of GLP-1 medications such as Ozempic triggers some changes.

United-states , American , Sabrena-joe , Sabrena-jo , Drug-administration , American-council-on-exercise , Novo-nordisk , American-council , Health-insurance , Ealth , Mall-business , Ersonal-finance

European regulator endorses high-dose version of Bayer eye drug Eylea

FRANKFURT (Reuters) -Bayer said on Friday that the European Medicines Agency recommended approval of a higher dose version of eye drug Eylea for treatment of a leading cause of blindness among the elderly, stepping up competition with Roche. The European Commission, which has the final word on drug approvals in the EU, typically follows the recommendations issued by the EMA. A go-ahead would mean that Eylea, an injection in the eye also known as aflibercept and jointly developed with Regeneron, can be given in doses of 8 milligrams instead of the usual 2 milligrams, allowing for longer intervals between injections.

Switzerland , Swiss , Matthias-williams , Ludwig-burger , Elaine-hardcastle , Reuters , European-medicines-agency , Drug-administration , European-commission , Uropean-commission , Ye-diseases , Ayer

These popular medicines might be pulled from shelves for a very strange reason

An advisory panel told the Food and Drug Administration that the highly sought-after medicines may no longer be suitable for sale.

Nevada , United-states , Jeff-greenberg-getty , Scott-melville , Procter-gamble , Jeffrey-greenberg-education-images-universal-group , Drug-administration , Walgreens , Johnson , Consumer-healthcare-products-association , Oral-phenylephrine , Nasal-decongestant

CVS is launching a genius way to cut costs for its customers

The drugstore is exploring new territory in a growing industry.

Switzerland , United-states , America , Swiss , Jeff-greenberg-getty , Prem-shah , Novartis , Jeffrey-greenberg-education-images-universal-group , Walmart , Free-report , Free-reportprime-day , Amazon-fresh

Passed out woman caught with coke, speed and Xanax: cops

HOBART — A woman passed out at a gas pump woman was caught with cocaine, methamphetamines, Xanax and two glass pipes, police said.

Amanda-reeder , Hobart-saturday , Lake-county , Obart , Rug-approvals , Rug-court , Rime ,

Muscular Dystrophy Association Tribute Awards in Washington

MDA Tribute Tour in Washington, D.C. includes raising awareness with Major League Baseball for Lou Gehrig Day with the Washington Nationals vs. ...

Miller-school , Pennsylvania , United-states , National-institutes-of-health , Maryland , University-of-pennsylvania , University-of-maryland , Washington , New-york , Houston , Texas , George-washington-school

Speedier drug approvals hit slowdown as FDA faces scrutiny

The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs

Washington , United-states , Robert-califf , Rick-pazdur , Reshma-ramachandran , Mike-sherman , Sam-kay , Yale-university , Drug-administration , Congress-do , Drug-approvals-pressure , Egislation

Drug slows Alzheimer's but can it make a real difference?

New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening

United-states , Japan , San-francisco , California , Japanese , Americans , Ron-petersen , Maria-carrillo , Mayo-petersen , Madhav-thambisetty , Michael-irizarry , Science-department

$3.5M gene therapy for hemophilia gets FDA approval

WASHINGTON (AP) — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder.

Washington , United-states , Peter-marks , Science-department , Drug-administration , Associated-press-health , Howard-hughes-medical-institute , Hemophilia-drug , Ealth-care-costs , Rescription-drug-costs , Iseases-and-conditions , Emophilia

Colorado votes on decriminalizing 'magic mushrooms'

Colorado voters are deciding whether theirs will be the second state, after Oregon, to decriminalize psychedelic mushrooms for those 21 and older. A ballot measure would create state-regulated “healing centers”

Colorado , United-states , Oregon , Arvada , Washington , Denver , Americans , Laura-owsly , James-hampl , Jesse-bedayn , Drug-administration , Associated-press